Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2024

03-01-2024 | Hepatic Encephalopathy | Original Article

Development and Evaluation of a Patient Cirrhosis Knowledge Assessment

Authors: Patricia P. Bloom, Zheng Che, Ashley Hyde, Emily Johnson, Antonio Miguel-Cruz, Michelle Carbonneau, Deepan Hazra, Puneeta Tandon

Published in: Digestive Diseases and Sciences | Issue 2/2024

Login to get access

Abstract

Background and Aims

Self-management skills improve outcomes for patients with cirrhosis. While education programs exist to teach these skills, there are limited patient assessments to evaluate their efficacy. We aimed to develop and evaluate cirrhosis knowledge assessments for patients with compensated and decompensated cirrhosis.

Methods

Across two institutions, a 4-stage process was undertaken: first, we developed a comprehensive set of questions regarding cirrhosis self-management. Second, the questions underwent critical review by patients and hepatology providers. Third, patients with cirrhosis answered these questions before and after a written educational tool. Questions were updated based on results. Fourth, patients answered the updated questions before and after a video educational tool. Binomial test or paired sample t-test was used to compare pre- and post-tests depending on question type.

Results

In phase 3, 134 patients completed pre- and post-tests. 44% were decompensated, 81% were diagnosed with cirrhosis at least 3 years, and 52% were 60–75 years. 95% of single-answer questions were answered correctly by at least 70% of patients in the pre-test. None of the answers improved significantly with education. After phase 3, 6 questions were removed and 6 questions were edited to increase challenge. In phase 4, 96 patients (42 compensated, 54 decompensated) completed pre- and post-tests. In the compensated assessment, 3 questions improved after education and the summative score increased (7.9 to 9.0, P < 0.001). In the decompensated assessment, 4 questions improved after education and the summative score increased (7.0 to 7.7, P = 0.004).

Conclusion

Through a rigorous process, we created and evaluated cirrhosis knowledge assessments for patients with compensated and decompensated cirrhosis. Further validation is required and then these assessments can be used to improve patient education.
Appendix
Available only for authorised users
Literature
3.
go back to reference Crabb DW, Im GY, Szabo G et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2020;71:306–333.CrossRefPubMed Crabb DW, Im GY, Szabo G et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2020;71:306–333.CrossRefPubMed
4.
go back to reference Ramachandran J, Woodman RJ, Muller KR et al. Validation of knowledge questionnaire for patients with liver cirrhosis. Clin Gastroenterol Hepatol 2020;18:1867-1873.e1.CrossRefPubMed Ramachandran J, Woodman RJ, Muller KR et al. Validation of knowledge questionnaire for patients with liver cirrhosis. Clin Gastroenterol Hepatol 2020;18:1867-1873.e1.CrossRefPubMed
5.
go back to reference IBM Corp. Released 2021. IBM SPSS Statistics for Windows. Armonk: IBM Corp; 2021. IBM Corp. Released 2021. IBM SPSS Statistics for Windows. Armonk: IBM Corp; 2021.
7.
go back to reference Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health 2019;40:127–146.CrossRefPubMedPubMedCentral Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health 2019;40:127–146.CrossRefPubMedPubMedCentral
8.
go back to reference Ismond KP, Loch-Ismond E, Tandon P et al. An evaluation of online cirrhosis-related information intended for patients and caregivers. Clin Gastroenterol Hepatol 2023;21:835-837.e8.CrossRefPubMed Ismond KP, Loch-Ismond E, Tandon P et al. An evaluation of online cirrhosis-related information intended for patients and caregivers. Clin Gastroenterol Hepatol 2023;21:835-837.e8.CrossRefPubMed
10.
go back to reference Goldsworthy MA, Fateen W, Thygesen H et al. Patient understanding of liver cirrhosis and improvement using multimedia education. Frontline Gastroenterol 2017;8:214–219.CrossRefPubMedPubMedCentral Goldsworthy MA, Fateen W, Thygesen H et al. Patient understanding of liver cirrhosis and improvement using multimedia education. Frontline Gastroenterol 2017;8:214–219.CrossRefPubMedPubMedCentral
11.
go back to reference Volk ML, Fisher N, Fontana RJ. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol 2013;108:302–305.CrossRefPubMed Volk ML, Fisher N, Fontana RJ. Patient knowledge about disease self-management in cirrhosis. Am J Gastroenterol 2013;108:302–305.CrossRefPubMed
12.
go back to reference Desai AP, Duzdar S, Stump T et al. Measuring medication use, obstacles, and knowledge in individuals with cirrhosis. Clin Gastroenterol Hepatol 2022;21:1819-1830.e5.CrossRefPubMed Desai AP, Duzdar S, Stump T et al. Measuring medication use, obstacles, and knowledge in individuals with cirrhosis. Clin Gastroenterol Hepatol 2022;21:1819-1830.e5.CrossRefPubMed
13.
go back to reference Beg S, Curtis S, Shariff M. Patient education and its effect on self-management in cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 2016;28:582–587.CrossRefPubMed Beg S, Curtis S, Shariff M. Patient education and its effect on self-management in cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 2016;28:582–587.CrossRefPubMed
14.
go back to reference Hayward KL, Valery PC, Patel PJ et al. Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis. Intern Med J 2020;50:1142–1146.CrossRefPubMedPubMedCentral Hayward KL, Valery PC, Patel PJ et al. Effectiveness of patient-oriented education and medication management intervention in people with decompensated cirrhosis. Intern Med J 2020;50:1142–1146.CrossRefPubMedPubMedCentral
15.
go back to reference de Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII—Renewing consensus in portal hypertension. J Hepatol 2022;76:959–974.CrossRefPubMed de Franchis R, Bosch J, Garcia-Tsao G et al. Baveno VII—Renewing consensus in portal hypertension. J Hepatol 2022;76:959–974.CrossRefPubMed
16.
go back to reference Lai JC, Tandon P, Bernal W et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611–1644.CrossRefPubMed Lai JC, Tandon P, Bernal W et al. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611–1644.CrossRefPubMed
17.
go back to reference U.S. Census. Educational Attainment in the US: 2018. U.S. Census; 2018. U.S. Census. Educational Attainment in the US: 2018. U.S. Census; 2018.
Metadata
Title
Development and Evaluation of a Patient Cirrhosis Knowledge Assessment
Authors
Patricia P. Bloom
Zheng Che
Ashley Hyde
Emily Johnson
Antonio Miguel-Cruz
Michelle Carbonneau
Deepan Hazra
Puneeta Tandon
Publication date
03-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08238-z

Other articles of this Issue 2/2024

Digestive Diseases and Sciences 2/2024 Go to the issue

Invited Commentary

IBD: Who Knows Best?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.